Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers-Reference-Cited by-同舟云学术

Cancer Metabolism: Strategic Diversion from Targeting Cancer Drivers to Targeting Cancer Suppliers

Published:2015-03-31 Issue:2 Volume:23 Page:99-109
ISSN:2005-4483
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Kim Soo-Youl¹

Affiliation:

1. Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 410-769, Republic of Korea

Funder

National Cancer Center(NCC)

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2015/023/bt-23-99.pdf

Reference52 articles.

1. The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer

2. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

3. A Missing Link in Genotype-Directed Cancer Therapy

4. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres;Journal of Neuro-Oncology;2022-11-17

2. Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines;Biomedicine & Pharmacotherapy;2022-07

3. Cancer Patient Tissueoid with Self‐Homing Nano‐Targeting of Metabolic Inhibitor;Advanced Science;2021-10-18

4. Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres;Molecules;2021-01-08

5. Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents;RSC Medicinal Chemistry;2021